363 related articles for article (PubMed ID: 26507858)
21. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
22. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
23. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.
Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
N Engl J Med; 1994 Sep; 331(13):836-41. PubMed ID: 8078529
[TBL] [Abstract][Full Text] [Related]
24. Immediate prophylactic vs endoscopic or symptomatic-driven azathioprine treatment to prevent surgical recurrence after intestinal resection for Crohn's disease.
Guo Z; Cai X; Liu R; Gong J; Li Y; Cao L; Wang Z; Zhu W
Colorectal Dis; 2018 Sep; 20(9):O267-O276. PubMed ID: 30051962
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome after ileocecal resection for Crohn's disease.
Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K; Chen SH
Am Surg; 1997 Jul; 63(7):627-33. PubMed ID: 9202538
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome of colectomy and ileorectal anastomosis for Crohn's colitis.
O'Riordan JM; O'Connor BI; Huang H; Victor JC; Gryfe R; MacRae HM; Cohen Z; McLeod RS
Dis Colon Rectum; 2011 Nov; 54(11):1347-54. PubMed ID: 21979177
[TBL] [Abstract][Full Text] [Related]
27. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of Crohn's disease: indications, results and predictive factors of recurrence and morbidity.
Hefaiedh R; Sabbeh M; Miloudi N; Ennaifer R; Romdhane H; Belhadj N; Gharbi L; Khalfallah T
Tunis Med; 2015 Jun; 93(6):356-60. PubMed ID: 26644097
[TBL] [Abstract][Full Text] [Related]
29. [Recurrence of Crohn's disease after surgery--causes and risks].
Mirow L; Hauenschild L; Hildebrand P; Kleemann M; Keller R; Franke C; Roblick UJ; Bruch HP; Kujath P
Zentralbl Chir; 2008 Apr; 133(2):182-7. PubMed ID: 18415909
[TBL] [Abstract][Full Text] [Related]
30. Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
Tremaine WJ; Hanauer SB; Katz S; Winston BD; Levine JG; Persson T; Persson A;
Am J Gastroenterol; 2002 Jul; 97(7):1748-54. PubMed ID: 12135030
[TBL] [Abstract][Full Text] [Related]
31. Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
Wenzl HH; Primas C; Novacek G; Teml A; Öfferlbauer-Ernst A; Högenauer C; Vogelsang H; Petritsch W; Reinisch W
Dig Dis Sci; 2015 May; 60(5):1414-23. PubMed ID: 25381202
[TBL] [Abstract][Full Text] [Related]
32. Single-incision laparoscopic surgery for ileocolic resection in Crohn's disease.
Rijcken E; Mennigen R; Argyris I; Senninger N; Bruewer M
Dis Colon Rectum; 2012 Feb; 55(2):140-6. PubMed ID: 22228156
[TBL] [Abstract][Full Text] [Related]
33. Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.
Dignass A; Stoynov S; Dorofeyev AE; Grigorieva GA; Tomsová E; Altorjay I; Tuculanu D; Bunganič I; Pokrotnieks J; Kupčinskas L; Dilger K; Greinwald R; Mueller R;
J Crohns Colitis; 2014 Sep; 8(9):970-80. PubMed ID: 24534142
[TBL] [Abstract][Full Text] [Related]
34. Split stoma in resectional surgery of high-risk patients with ileocolonic Crohn's disease.
Myrelid P; Söderholm JD; Olaison G; Sjödahl R; Andersson P
Colorectal Dis; 2012 Feb; 14(2):188-93. PubMed ID: 21689286
[TBL] [Abstract][Full Text] [Related]
35. A positive proximal resection margin is associated with anastomotic complications following primary ileocaecal resection for Crohn's disease.
Garofalo E; Lucarini A; Flashman KG; Celentano V
Int J Colorectal Dis; 2019 Sep; 34(9):1585-1590. PubMed ID: 31377853
[TBL] [Abstract][Full Text] [Related]
36. Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.
Andus T; Gross V; Caesar I; Schulz HJ; Lochs H; Strohm WD; Gierend M; Weber A; Ewe K; Schölmerich J;
Dig Dis Sci; 2003 Feb; 48(2):373-8. PubMed ID: 12643618
[TBL] [Abstract][Full Text] [Related]
37. [Surgical treatment for Crohn's disease].
Panis Y
Ann Chir; 2002 Jan; 127(1):9-18. PubMed ID: 11833314
[TBL] [Abstract][Full Text] [Related]
38. Single-port versus multiport laparoscopic ileocecal resection for Crohn's disease.
Gardenbroek TJ; Verlaan T; Tanis PJ; Ponsioen CY; D'Haens GR; Buskens CJ; Bemelman WA
J Crohns Colitis; 2013 Nov; 7(10):e443-8. PubMed ID: 23507422
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic versus open ileo-colonic resection in Crohn's disease: short- and long-term results from a prospective longitudinal study.
Sica GS; Iaculli E; Benavoli D; Biancone L; Calabrese E; Onali S; Gaspari AL
J Gastrointest Surg; 2008 Jun; 12(6):1094-102. PubMed ID: 18027061
[TBL] [Abstract][Full Text] [Related]
40. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
Vilien M; Dahlerup JF; Munck LK; Nørregaard P; Grønbaek K; Fallingborg J
Aliment Pharmacol Ther; 2004 Jun; 19(11):1147-52. PubMed ID: 15153167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
